Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer.

Loosen SH, Breuer A, Tacke F, Kather JN, Gorgulho J, Alizai PH, Bednarsch J, Roeth AA, Lurje G, Schmitz SM, Brozat JF, Paffenholz P, Vucur M, Ritz T, Koch A, Trautwein C, Ulmer TF, Roderburg C, Longerich T, Neumann UP, Luedde T.

JHEP Rep. 2020 Jan 31;2(2):100080. doi: 10.1016/j.jhepr.2020.100080. eCollection 2020 Apr.

2.

Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic Cancer.

Loosen SH, Luedde M, Lurje G, Spehlmann M, Paffenholz P, Ulmer TF, Tacke F, Vucur M, Trautwein C, Neumann UP, Luedde T, Roderburg C.

Dis Markers. 2019 Oct 20;2019:5603474. doi: 10.1155/2019/5603474. eCollection 2019.

3.

Serum Levels of miR-143 Predict Survival in Critically Ill Patients.

Roderburg C, Koch A, Benz F, Vucur M, Spehlmann M, Loosen SH, Luedde M, Rehse S, Lurje G, Trautwein C, Tacke F, Luedde T.

Dis Markers. 2019 Oct 23;2019:4850472. doi: 10.1155/2019/4850472. eCollection 2019.

4.

[Unknown liver lesions].

Roderburg C, Loosen SH, Bruners P, Luedde T.

Dtsch Med Wochenschr. 2019 Nov;144(23):1651-1664. doi: 10.1055/a-0733-6122. Epub 2019 Nov 21. German.

PMID:
31752038
5.

A Combined Score of Circulating miRNAs Allows Outcome Prediction in Critically Ill Patients.

Roderburg C, Benz F, Koch A, Loosen SH, Spehlmann M, Luedde M, Wree A, Vucur M, Trautwein C, Tacke F, Luedde T.

J Clin Med. 2019 Oct 9;8(10). pii: E1644. doi: 10.3390/jcm8101644.

6.

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies.

Loosen SH, Schulze-Hagen M, Bruners P, Tacke F, Trautwein C, Kuhl C, Luedde T, Roderburg C.

Cancers (Basel). 2019 Oct 8;11(10). pii: E1503. doi: 10.3390/cancers11101503.

7.

The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis.

Loosen SH, Koch A, Tacke F, Roderburg C, Luedde T.

Int J Mol Sci. 2019 Sep 28;20(19). pii: E4820. doi: 10.3390/ijms20194820. Review.

8.

Excellent Response to Anti-PD-1 Therapy in a Patient with Hepatocellular Carcinoma Intolerant to Sorafenib.

Roderburg C, Berres ML, Wree A, Loosen SH, Luedde T, Trautwein C.

Visc Med. 2019 Mar;35(1):43-46. doi: 10.1159/000497465. Epub 2019 Feb 12.

9.

Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer.

Kather JN, Pearson AT, Halama N, Jäger D, Krause J, Loosen SH, Marx A, Boor P, Tacke F, Neumann UP, Grabsch HI, Yoshikawa T, Brenner H, Chang-Claude J, Hoffmeister M, Trautwein C, Luedde T.

Nat Med. 2019 Jul;25(7):1054-1056. doi: 10.1038/s41591-019-0462-y. Epub 2019 Jun 3.

10.

Efficacy of the Oestrogen Antagonist Tamoxifen on Sperm Parameters in Patients with Idiopathic Oligoathenoteratozoospermia.

Paffenholz P, Votteler S, Nazari S, Nestler T, Salem J, Grabbert M, von Brandenstein M, Loosen SH, Zey S, Heidenreich A, Herden J, Denil J.

Urol Int. 2019;103(1):108-115. doi: 10.1159/000500301. Epub 2019 May 8.

PMID:
31067562
11.

Diagnostic and prognostic biomarkers in cholangiocarcinoma.

Macias RIR, Kornek M, Rodrigues PM, Paiva NA, Castro RE, Urban S, Pereira SP, Cadamuro M, Rupp C, Loosen SH, Luedde T, Banales JM.

Liver Int. 2019 May;39 Suppl 1:108-122. doi: 10.1111/liv.14090. Review.

PMID:
30843325
12.

High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma.

Loosen SH, Tacke F, Püthe N, Binneboesel M, Wiltberger G, Alizai PH, Kather JN, Paffenholz P, Ritz T, Koch A, Bergmann F, Trautwein C, Longerich T, Roderburg C, Neumann UP, Luedde T.

Carcinogenesis. 2019 Aug 22;40(8):947-955. doi: 10.1093/carcin/bgz033.

13.

Elevated serum levels of bone sialoprotein (BSP) predict long-term mortality in patients with pancreatic adenocarcinoma.

Loosen SH, Hoening P, Puethe N, Luedde M, Spehlmann M, Ulmer TF, Cardenas DV, Roy S, Tacke F, Trautwein C, Neumann UP, Luedde T, Roderburg C.

Sci Rep. 2019 Feb 6;9(1):1489. doi: 10.1038/s41598-018-38352-2.

14.

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.

Loosen SH, Lurje G, Wiltberger G, Vucur M, Koch A, Kather JN, Paffenholz P, Tacke F, Ulmer FT, Trautwein C, Luedde T, Neumann UP, Roderburg C.

PLoS One. 2019 Jan 17;14(1):e0210944. doi: 10.1371/journal.pone.0210944. eCollection 2019.

15.

Circulating Levels of Osteopontin Predict Patients' Outcome after Resection of Colorectal Liver Metastases.

Loosen SH, Heise D, Dejong CH, Roy S, Tacke F, Trautwein C, Roderburg C, Luedde T, Neumann UP, Binnebösel M.

J Clin Med. 2018 Oct 26;7(11). pii: E390. doi: 10.3390/jcm7110390.

16.

Serum levels of kisspeptin are elevated in critically ill patients.

Luedde M, Spehlmann ME, Hippe HJ, Loosen SH, Roy S, Vargas Cardenas D, Vucur M, Frey N, Koch A, Luedde T, Trautwein C, Tacke F, Roderburg C.

PLoS One. 2018 Oct 17;13(10):e0206064. doi: 10.1371/journal.pone.0206064. eCollection 2018.

17.

Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer.

Pombeiro I, Loosen SH, Roy S, Schueller F, Niewenhuisen L, Luedde M, Vucur M, Tacke F, Binnebösel M, Schoening W, Trautwein C, Luedde T, Neumann UP, Roderburg C.

J Clin Med. 2018 Jul 13;7(7). pii: E175. doi: 10.3390/jcm7070175.

18.

Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases.

Loosen SH, Tacke F, Binnebosel M, Leyh C, Vucur M, Heitkamp F, Schoening W, Ulmer TF, Alizai PH, Trautwein C, Koch A, Longerich T, Roderburg C, Neumann UP, Luedde T.

Oncotarget. 2018 Jun 5;9(43):27027-27038. doi: 10.18632/oncotarget.25471. eCollection 2018 Jun 5.

19.

IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies.

Loosen SH, Schulze-Hagen M, Leyh C, Benz F, Vucur M, Kuhl C, Trautwein C, Tacke F, Bruners P, Roderburg C, Luedde T.

Int J Mol Sci. 2018 Jun 14;19(6). pii: E1766. doi: 10.3390/ijms19061766.

20.

Circulating Biomarkers for Cholangiocarcinoma.

Loosen SH, Vucur M, Trautwein C, Roderburg C, Luedde T.

Dig Dis. 2018;36(4):281-288. doi: 10.1159/000488342. Epub 2018 May 15. Review.

PMID:
29807369

Supplemental Content

Loading ...
Support Center